Catheter Directed Thrombolytic Therapy in Pulmonary Embolism

Gabby Elbaz-Greener; Ronny Alcalai; Eyal Herzog; Allan I. Bloom; David Planer

doi:10.1007/978-3-030-87090-4_12

Catheter Directed Thrombolytic Therapy in Pulmonary Embolism

Gabby Elbaz-Greener
, Ronny Alcalai
, Eyal Herzog
, Allan I. Bloom
, David Planer

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Pulmonary embolism (PE) is the third leading cause of morbidity and mortality from cardiovascular disease worldwide. Catheter-directed thrombolytic (CDT) therapy is one of the newest treatment options for patients with intermediate-high risk PE and for selected patients with high risk PE. Infusion of low dose thrombolytic agent is given intra-vasculary directly into the embolus located within the pulmonary artery. Several studies in the past decade have supported the safety and efficacy of CDT. In this chapter we review the technique, indications, contraindications and potential complications of the procedure.

Original language	English
Title of host publication	Pulmonary Embolism
Publisher	Springer International Publishing
Pages	171-183
Number of pages	13
ISBN (Electronic)	9783030870904
ISBN (Print)	9783030870898
DOIs	https://doi.org/10.1007/978-3-030-87090-4_12
State	Published - 1 Jan 2021
Externally published	Yes

Keywords

CDT
Catheter-Directed Thrombolysis
PERT
Pulmonary Embolism
Pulmonary Embolism Response Team
Pulmonary Intervention
USCDT
Ultrasound Assisted Catheter Direct Thrombolysis

Access to Document

10.1007/978-3-030-87090-4_12

Cite this

@inbook{4354854bd710497db7123286c32f71ba,

title = "Catheter Directed Thrombolytic Therapy in Pulmonary Embolism",

abstract = "Pulmonary embolism (PE) is the third leading cause of morbidity and mortality from cardiovascular disease worldwide. Catheter-directed thrombolytic (CDT) therapy is one of the newest treatment options for patients with intermediate-high risk PE and for selected patients with high risk PE. Infusion of low dose thrombolytic agent is given intra-vasculary directly into the embolus located within the pulmonary artery. Several studies in the past decade have supported the safety and efficacy of CDT. In this chapter we review the technique, indications, contraindications and potential complications of the procedure.",

keywords = "CDT, Catheter-Directed Thrombolysis, PERT, Pulmonary Embolism, Pulmonary Embolism Response Team, Pulmonary Intervention, USCDT, Ultrasound Assisted Catheter Direct Thrombolysis",

author = "Gabby Elbaz-Greener and Ronny Alcalai and Eyal Herzog and Bloom, \{Allan I.\} and David Planer",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-87090-4\_12",

language = "English",

isbn = "9783030870898",

pages = "171--183",

booktitle = "Pulmonary Embolism",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Catheter Directed Thrombolytic Therapy in Pulmonary Embolism

AU - Elbaz-Greener, Gabby

AU - Alcalai, Ronny

AU - Herzog, Eyal

AU - Bloom, Allan I.

AU - Planer, David

N1 - Publisher Copyright: © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Pulmonary embolism (PE) is the third leading cause of morbidity and mortality from cardiovascular disease worldwide. Catheter-directed thrombolytic (CDT) therapy is one of the newest treatment options for patients with intermediate-high risk PE and for selected patients with high risk PE. Infusion of low dose thrombolytic agent is given intra-vasculary directly into the embolus located within the pulmonary artery. Several studies in the past decade have supported the safety and efficacy of CDT. In this chapter we review the technique, indications, contraindications and potential complications of the procedure.

AB - Pulmonary embolism (PE) is the third leading cause of morbidity and mortality from cardiovascular disease worldwide. Catheter-directed thrombolytic (CDT) therapy is one of the newest treatment options for patients with intermediate-high risk PE and for selected patients with high risk PE. Infusion of low dose thrombolytic agent is given intra-vasculary directly into the embolus located within the pulmonary artery. Several studies in the past decade have supported the safety and efficacy of CDT. In this chapter we review the technique, indications, contraindications and potential complications of the procedure.

KW - CDT

KW - Catheter-Directed Thrombolysis

KW - PERT

KW - Pulmonary Embolism

KW - Pulmonary Embolism Response Team

KW - Pulmonary Intervention

KW - USCDT

KW - Ultrasound Assisted Catheter Direct Thrombolysis

UR - https://www.scopus.com/pages/publications/85156264595

U2 - 10.1007/978-3-030-87090-4_12

DO - 10.1007/978-3-030-87090-4_12

M3 - Chapter

AN - SCOPUS:85156264595

SN - 9783030870898

SP - 171

EP - 183

BT - Pulmonary Embolism

PB - Springer International Publishing

ER -

Catheter Directed Thrombolytic Therapy in Pulmonary Embolism

Abstract

Keywords

Access to Document

Fingerprint

Cite this